Skip to content

Rare Cancer

Catalog entries using this tag (links open the entry card on its page):

Entries

KEEP

AI Imaging Pathology Foundation Model Vision-Language Knowledge Graph Rare Cancer Cancer Cell
PUBMED_LINK
41720085
FULL NAME
KEEP — Knowledge-Enhanced Pathology Vision-Language Foundation Model
DESCRIPTION
KEEP (KnowledgE-Enhanced Pathology) is a vision-language foundation model from Shanghai AI Lab / SJTU that systematically integrates disease knowledge into pretraining for cancer diagnosis. Uses a comprehensive disease knowledge graph with 11,454 diseases and 139,143 attributes from DO and UMLS to reorganize millions of pathology image-text pairs into 143,000 semantically structured groups aligned with disease ontology hierarchies. Across 18 public benchmarks (14,000+ WSIs) and 4 institutional rare cancer datasets (926 cases), KEEP consistently outperforms existing foundation models (CHIEF, CONCH, UNI), with substantial gains for rare subtypes (+8.5 pts balanced accuracy vs CONCH on 30 rare brain cancers). Published in Cancer Cell, Feb 2026.
URL
https://github.com/MAGIC-AI4Med/KEEP
TITLE
Knowledge-enhanced pretraining for vision-language pathology foundation model on cancer diagnosis.
Main citation
Zhou X, Sun L, He D, Guan W, Wang G, Wang R, Wang L, Yuan X, Sun X, Zhang Y, Sun K, Wang Y, Xie W. (2026) Knowledge-enhanced pretraining for vision-language pathology foundation model on cancer diagnosis. Cancer Cell, 44(4):777-791. doi:10.1016/j.ccell.2026.01.019. PMID 41720085
ABSTRACT
Vision-language foundation models have shown great promise in computational pathology but remain primarily data-driven, lacking explicit integration of medical knowledge. We introduce KEEP, a foundation model that systematically incorporates disease knowledge into pretraining for cancer diagnosis. KEEP leverages a comprehensive disease knowledge graph encompassing 11,454 diseases and 139,143 attributes to reorganize millions of pathology image-text pairs into 143,000 semantically structured groups aligned with disease ontology hierarchies. Across 18 public benchmarks (over 14,000 WSIs) and 4 institutional rare cancer datasets (926 cases), KEEP consistently outperformed existing foundation models, showing substantial gains for rare subtypes.
DOI
10.1016/j.ccell.2026.01.019

Virchow

AI Imaging Pathology Foundation Model Paige Microsoft Rare Cancer Self-Supervised
PUBMED_LINK
39080966
FULL NAME
Virchow — Million-Scale Digital Pathology Foundation Model (Paige/Microsoft)
DESCRIPTION
Virchow is the first million-slide foundation model for computational pathology, developed by Paige in collaboration with Microsoft. A 632M-parameter ViT-H model trained using DINOv2 on 1.5 million H&E-stained WSIs from MSKCC (17 tissue types). Demonstrates clinical-grade pan-cancer detection with 0.95 AUC across nine common and seven rare cancers. With less training data, the pan-cancer detector built on Virchow achieves similar performance to tissue-specific clinical-grade models in production, outperforming them on rare cancer variants. Serves as the foundation for Paige's Virchow2 (3M WSIs, multimodal) and Virchow2G (1.8B parameters) models.
URL
https://huggingface.co/paige-ai/Virchow
TITLE
A foundation model for clinical-grade computational pathology and rare cancers detection.
Main citation
Vorontsov E, Bozkurt A, Casson A, Shaikovski G, Zelechowski M, Severson K, Zimmermann E, Hall J, Tenenholtz N, Fusi N, Yang E, Mathieu P, van Eck A, Lee D, Viret J, Robert E, Wang YK, Kunz JD, Lee MCH, Bernhard JH, Godrich RA, Oakley G, Millar E, Hanna M, Wen H, Retamero JA, Moye WA, Yousfi R, Kanan C, Klimstra DS, Rothrock B, Liu S, Fuchs TJ. (2024) A foundation model for clinical-grade computational pathology and rare cancers detection. Nature Medicine, 30(10):2924-2935. doi:10.1038/s41591-024-03141-0. PMID 39080966
ABSTRACT
The analysis of histopathology images with artificial intelligence aims to enable clinical decision support systems and precision medicine. We present Virchow, the largest foundation model for computational pathology to date. In addition to the evaluation of biomarker prediction and cell identification, we demonstrate that a large foundation model enables pan-cancer detection, achieving 0.95 specimen-level AUC across nine common and seven rare cancers. With less training data, the pan-cancer detector built on Virchow achieved similar performance to tissue-specific clinical-grade models in production and outperformed them on some rare variants of cancer.
DOI
10.1038/s41591-024-03141-0